Trinity™ BIOLOX Delta™ CoC THR Multi-center Study
Public ClinicalTrials.gov record NCT01921309. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Phase 3 Randomized Controlled Study to Demonstrate Safety and Effectiveness of the BIOLOX Delta CoC THR System
Study identification
- NCT ID
- NCT01921309
- Recruitment status
- Not listed
- Study type
- Interventional
- Phase
- Not applicable
- Lead sponsor
- Corin
- Industry
- Enrollment
- 342 participants
Conditions and interventions
Conditions
Interventions
- Trinity Ceramic-on-Poly THR Device
- Trinity CoC Total Hip System Device
Device
Eligibility (public fields only)
- Age range
- 18 Years to 80 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Nov 30, 2012
- Primary completion
- Aug 31, 2021
- Completion
- Nov 30, 2021
- Last update posted
- Mar 10, 2021
2012 – 2021
United States locations
- U.S. sites
- 9
- U.S. states
- 7
- U.S. cities
- 8
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Arkansas Specialty Orthopaedics | Little Rock | Arkansas | 72205 | — |
| Denver Hip and Knee, Inc. | Parker | Colorado | 80134 | — |
| Connecticut Joint Replacement Institute (CJRI) | Hartford | Connecticut | 06105 | — |
| Mayo Clinic Jacksonville | Jacksonville | Florida | 32224 | — |
| Florida Orthopaedic Institute | Tampa | Florida | 33609 | — |
| FMC Orthopedic Division | Tampa | Florida | 33613 | — |
| Resurgens Orthopaedics | Austell | Georgia | 30106 | — |
| OrthoCarolina Hip & Knee Center | Charlotte | North Carolina | 28207 | — |
| Memorial Bone & Joint | Houston | Texas | 77043 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 1 non-U.S. site.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01921309, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Mar 10, 2021 · Synced May 18, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT01921309 live on ClinicalTrials.gov.